Emerphed Injection
Product Images NDC 14789-250

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Emerphed (NDC 14789-250). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nexus Pharamaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eph07 0003 01

Chemical structure of Ephedrine Sulfate, showing the molecular arrangement of the ephedrine molecule complexed with sulfate.*

FDA Label Image

Eph07 0003 02

FDA Label Image

Eph07 0003 03

Emerphed (ephedrine sulfate) Injection 5 mg/mL is a human prescription drug presented in single-dose vials for intravenous use. The carton displays the 50 mg/10 mL strength (5 mg/mL), specifies it as a premixed formulation not to be diluted, and indicates a package containing 10 x 10 mL single-dose vials. The labeler is Nexus Pharmaceuticals Inc., Lincolnshire, IL.*

FDA Label Image

Eph07 0003 04

Label for Emerphed (ephedrine sulfate) Injection, 5 mg/mL, in a 10 mL single-dose vial for intravenous use. The label includes the concentration of 50 mg per 10 mL (5 mg/mL) equivalent to 38 mg ephedrine base per 10 mL. It is a premixed formulation labeled for intravenous use only, manufactured by Nexus Pharmaceuticals Inc. in the USA. Storage and usage instructions, barcode, and lot/expiration fields are also shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.